Pharmacovigilance as a discipline should not be confined to regulatory compliance. Leading life sciences companies are using it to shape a number of strategic priorities, from M&A decisions to product innovation. Compliance activities consume so much budget and so many resources that it is in companies’ best interests that they be able to exploit those…